Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132173) titled 'Analysis of the Efficacy and Safety of Tegileridine Fumarate Injection for Postoperative Analgesia Following Gynecological Laparoscopic Surgery' on Sept. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Hospital of Jilin University
Condition:
Postoperative Pain Following Gynecological Laparoscopy
Intervention:
Group A:Tegileridine 0.75 mg/5 mL for Intravenous Injection
Group D:Saline solution 5 mL for intravenous injection
Group B:Tegileridine 1.0 mg/5 mL for Intravenous Injection
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-31...